Радиационно-индуцированная болезнь сердца

1. Adams M.J. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. / M.J. Adams, S.R. Lipsitz, S.D. Colan et all. // J. Clin. Oncol. – 2004. – vol. 22. – p. 3139-3148.

2. Adams M.J. Radiation-associated cardiovascular disease: manifestations and management. / M.J. Adams, S.E. Lipshultz, C. Schwartz et all. // Semin. Radiat. Oncol. – 2003. – vol. 13. – p. 346-356.

3. Basavaraju S.R. Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. / S.R. Basavaraju, C.E. Easterly. // Med Phys. – 2002. – vol. 29. – p. 2391-2403.

4. Bennet B., Repacholi M., Carr Z. Health effects of the Chernobyl accident and special health care programmes. – Geneva: WHO Library Cataloguing-in-Publication Data, 2006. – 182 p.

5. Brugts J.J., Yetgin T., Hoeks S.E. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. // BMJ.– 2009; 338: b2376. (URL: http://www.bmj.com/cgi/content/abstract/338/jun30_1/b2376)

6. Carr Z.A. Coronary heart disease after radiotherapy for peptic ulcer disease. / Z.A. Carr, C.E. Land, R.A. Kleinerman et all. // Int. J. Radiat. Oncol. Biol. Phys. – 2005. – vol. 61. – p. 842-850.

7. Chan A.T., Manson J.E., Feskanich D. et al. Long-term Aspirin Use and Mortality in Women. // Arch. Intern. Med. – 2007. – vol. 167. – p. 562-572.

8. Clarke M. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. / M. Clarke, R. Collins, S. Darby et al. // Lancet. – 2005. – vol. 366. – p. 2087-2106.

9. Dale K., Coleman C., Henyan N. et all. Statins and cancer risk, a meta-analysis. JAMA, 2006, 295 (1), 74-80.

10. Darby S. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90,000 Swedish women. / S. Darby, P. Mcgale, R. Peto at all. // Br. Med. J. – 2003. – vol. 326. – p. 256-257.

11. Demierre M., Higgins P., Gruber S. et all. Statins and cancer prevention. Nat. Rev. Cancer. 2005, 5 (12), 930-942.

12. Gaya A.M. Cardiac complications of radiation therapy. / A.M. Gaya, R.F. Ashford. // Clin. Oncol. (R. Coll. Radiol.) – 2005. – vol. 17 (3). – p. 153-159.

13. Giordano S.H. Risk of cardiac death after adjuvant radiotherapy for breast cancer. / S.H. Giordano, Y.F. Kuo, J.L. Freeman et al. // J. Natl. Cancer Inst. –2005. – vol. 97. – p. 419-424.

14. Girinsky T. Pulmonary and cardiac late effects of ionizing radiations alone or combined with chemotherapy. / T. Girinsky, J.M. Cosset. // Cancer Radiother. – 1997. – vol. 1(6). – p. 735-743.

15. Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin’s disease in children and adolescents. // J. Clin. Oncol. – 1993. – vol. 11. – p. 1208-1215.

16. Harris Eleanor E.R. Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation Treatment. / Eleanor E.R. Harris, Candace Correa, Wei-Ting Hwang et all. // Journal of Clinical Oncology. – 2006. – vol. 25 (24). – p. 4100-4106.

17. Heidenreich P. A. Asymptomatic cardiac disease following mediastinal irradiation. / P.A. Heidenreich, S.L. Hancock, B.K. Lee, C.S. Mariscal. // J. Am. Coll. Cardiol. – 2003. – vol. 42. – p. 743-749.

18. Heidenreich P.A. Radiation induced heart disease: systemic disorders in heart disease. / P.A. Heidenreich, J.R. Kapoor. // Heart. – 2009. – vol. 95. – p. 252-258.

19. Heidenreich P.A., Schnittger I., Strauss H.W. et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. // J. Clin. Oncol. – 2007. – vol. 25. – p. 43-49.

20. Holmes M.D., Chen W.Y., Li L. et all. Aspirin Intake and Survival After Breast Cancer. // Journal of Clinical Oncology. – 2009. – 10.1200/JCO.2009.22.7918 (URL: http://jco.ascopubs.org/cgi/content/abstract/JCO.2009.22.7918v1)

21. Ivanov V.K. Radiation-epidemiological analysis of incidence of non-cancer diseases among the Chernobyl liquidators. / V.K. Ivanov, M.A. Maksioutov, S. Chekin et all. // Health Phys. – 2000. – vol. 78. – p. 495-501.

22. Jacobs E., Rodriguez C., Brady K. et all. Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. J. Natl. Cancer Inst., 2006, 98 (1), 69-72.

23. Jurcut R. Between Scylla and Charybdis: Long-Term Cardiovascular Complications After Radiotherapy for Hodgkin’s Lymphoma. / R. Jurcut, O. Savu, S. Giusca, D. Deleanu, R. Ciudin, C. Ginghina. // Hellenic J. Cardiol. – 2009. – vol. 50. – p. 538-543.

24. Jurcut R., Wildiers H., Ganame J. et all. Detection and monitoring of cardiotoxicity-what does modern cardiology offer? // Support Care Cancer. – 2008. – vol. 16. – p. 437-445.

25. King V., Constine L.S., Clark D. et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin’s disease. // Int. J. Radiat. Oncol. Biol. Phys. – 1996. – vol. 36. – p. 881-889.

26. Kruse J.J.C.M. Effects of Amifostine on Radiation-induced Cardiac Damage. // Acta Oncologica. – 2003. – vol. 1 (42). – p. 4-9.

27. Mauch P. Long-term survival in Hodgkin’s disease: relative impact of mortality, second tumors, infection and cardiovascular disease. / P. Mauch, L.A. Kalish, K.C. Marcus et al. // Cancer J. Sci. Am. – 1995. – vol. 1. – p. 33-42.

28. Patrono C., Rocca B. Aspirin: promise and resistance in millennium. // Arterioscler. Tromb. Vasc. Biol. – 2008. – vol. 28. – p. 25-32.

29. Schultz-Hector S. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiological data? / S . Schultz-Hector, K.R. Trott. // Int. J. Radiat. Oncol. Biol. Phys. – 2007. – vol. 67. – p. 10-18.

30. Sebag-Montefiore D., Hope-Stone H. Radiation induced coronary heart disease. // Br. Heart J. – 1993. – vol. 69. – p. 481-482.

31. Vondermark D., Seufert I., Schwab F. et al. 3-D reconstruction of anterior mantle-filed techniques in Hodgkin’s diasease survivors: doses to cardiac structures. / D. Vondermark, I. Seufert, F. Schwab et al. // Radiation Oncology. – 2006. – vol. 1. – p. 10.

32. Waksman R., King S., Croser I., Mould R. Vaskular brachytherapy, Veendaal, Nukletron, 1996. 382 p.

33. Wildon R. Farwell, Richard E. Scranton et all. The Association Between Statins and Cancer Incidence in a Veterans Population. // Journal of the National Cancer Institute. – 2008. – vol. 100 (2). – p. 134-139.

34. Важенин А.В. // Современное состояние и перспективы развития клинической онкологии в Челябинской области. – Челябинск: Иероглиф, 2001. – 43 с.

35. Воробьев Е.И. Радиационная кардиология. / Е.И. Воробьёв. – М.: Атомиздат, 1971. – 266 с.

36. Москалёв Ю.И. Отдалённые последствия ионизирующих излучений. / Ю.И. Москалёв. – М.: Медицина, 1991. – 463 с.

P.S. Статья была опубликована в журнале «Российский семейный врач». – 2010. – № 4 (том 14). – стр. 33-37. Скачать журнальный вариант.

Далее в файле Радиационно-индуцированная болезнь сердца

• Заболевания сердца после лучевой терапии - доказанная взаимосвязь.

• Структура постлучевой патологии и механизм повреждения.

• Стратегия курации: методы скрининга и профилактики.

• Список литературы. Журнальный вариант статьи.